+
Veerhealth Signs Contract Manufacturing Deal with Top Marketplace
ECONOMY & POLICY

Veerhealth Signs Contract Manufacturing Deal with Top Marketplace

Veerhealth Care, Ayuveer, backed by Veerhealth Care's expertise in Ayurveda, specializes in crafting ayurvedic medicines and oral care products with natural ingredients. With a focus on quality and affordability, Ayuveer aims to offer an exceptional and safe daily care experience to its customers.

Veerhealth Care has entered into a strategic Contract Manufacturing Agreement with a company having top position in personal care segment on marketplace companies in the country for the production of its private-label personal care range of products.

Under the terms of the agreement, company will manufacture and supply personal care range of products exclusively tailored to the company's brand specifications and quality standards. Company is in the process of regulatory approval which is expected to be completed soon and commercial production is expected to begin soon.

This development is expected to have a positive impact on the company's revenue and capacity utilisation in the coming quarters.

Commenting on the achievement, Bhavin Shah - Managing Director of Veerhealth Care, said, “We are exhilarated to announce this partnership which marks a significant milestone in company's growth strategy, further strengthening our position in the personal care manufacturing sector.

To meet the increased demand from both Domestic and Exports, Company will be operating at Full capacity which will help in reducing the overall costs and boosting Total Income and PAT. In coming Quarters, we expect to more than fully recover the reduction in Total Income and PAT caused by USFDA Inspection as dispatches for Exports have started.

We are working aggressively towards business of manufacturing and exports of products under medical device category in the US. Company is expected to complete formalities pertaining to the medical device category with the USFDA.

Our ability to secure multiple high-value export orders, including those from top institutional suppliers, underscores the trust in our product, quality and commitment to excellence. The expansion of our manufacturing footprint further reflects our proactive approach to meeting growing demand and enhancing our production capabilities. These achievements are a testament to our strategy and pave the way for sustained growth and value creation in the coming quarters."

For successfully clearing the USFDA Inspection the Company had to expand, renovate and upgrade the Manufacturing facility due to which Production was impacted in the past 6-9 months, also Exports were halted for USFDA clearance which resulted in Inventory pile up. Company has now started dispatching for Exports.

Products / Services offered by Veerhealth Care:

Contract Manufacturing – Veerhealth Care manufacture products on behalf of Brands to meet their requirements. The Brands give the company specifications about the products to be manufactured.

White Labelling – Veerhealth Care manufactures generic products that retailers can sell under their own Brands.

Product Research & Development – Veerhealth Care has extensive in-house R&D facility for designing, testing and manufacturing. Company has the capability of creating various new products. Till now Company has launched more than 100 products through this.

Customised Product Formulations – Veerhealth Care has the capability of manufacturing specialised product formulations customised for the Brands. Due to customisation the products can meet the standard specifications of the Brands.

Veerhealth Care has established a new division focused on hospital care, which includes partnering with a leading manufacturer and exporter of medical equipment. This new division will offer a range of equipment, including ventilators, defibrillators, infusion pumps, syringe pumps, and other accessories. Company intends to supply these products to government organizations and hospitals.

VeerPlast is a division of Veerhealth Care. It is a plastic moulding company, providing high-quality plastic products to various industries. At VeerPlast, Company takes pride in being a manufacturer of high-quality toothbrushes, dedicated to promoting superior oral hygiene through precision and commitment to excellence.

The Company is expecting to get a substantial addition to its revenue in the current financial year. In F.Y. 2025-26, Company is expecting Total Revenues of Rs 305-400 million with PAT of 10 per cent.


Veerhealth Care, Ayuveer, backed by Veerhealth Care's expertise in Ayurveda, specializes in crafting ayurvedic medicines and oral care products with natural ingredients. With a focus on quality and affordability, Ayuveer aims to offer an exceptional and safe daily care experience to its customers.Veerhealth Care has entered into a strategic Contract Manufacturing Agreement with a company having top position in personal care segment on marketplace companies in the country for the production of its private-label personal care range of products.Under the terms of the agreement, company will manufacture and supply personal care range of products exclusively tailored to the company's brand specifications and quality standards. Company is in the process of regulatory approval which is expected to be completed soon and commercial production is expected to begin soon.This development is expected to have a positive impact on the company's revenue and capacity utilisation in the coming quarters.Commenting on the achievement, Bhavin Shah - Managing Director of Veerhealth Care, said, “We are exhilarated to announce this partnership which marks a significant milestone in company's growth strategy, further strengthening our position in the personal care manufacturing sector.To meet the increased demand from both Domestic and Exports, Company will be operating at Full capacity which will help in reducing the overall costs and boosting Total Income and PAT. In coming Quarters, we expect to more than fully recover the reduction in Total Income and PAT caused by USFDA Inspection as dispatches for Exports have started.We are working aggressively towards business of manufacturing and exports of products under medical device category in the US. Company is expected to complete formalities pertaining to the medical device category with the USFDA.Our ability to secure multiple high-value export orders, including those from top institutional suppliers, underscores the trust in our product, quality and commitment to excellence. The expansion of our manufacturing footprint further reflects our proactive approach to meeting growing demand and enhancing our production capabilities. These achievements are a testament to our strategy and pave the way for sustained growth and value creation in the coming quarters.For successfully clearing the USFDA Inspection the Company had to expand, renovate and upgrade the Manufacturing facility due to which Production was impacted in the past 6-9 months, also Exports were halted for USFDA clearance which resulted in Inventory pile up. Company has now started dispatching for Exports.Products / Services offered by Veerhealth Care:Contract Manufacturing – Veerhealth Care manufacture products on behalf of Brands to meet their requirements. The Brands give the company specifications about the products to be manufactured.White Labelling – Veerhealth Care manufactures generic products that retailers can sell under their own Brands.Product Research & Development – Veerhealth Care has extensive in-house R&D facility for designing, testing and manufacturing. Company has the capability of creating various new products. Till now Company has launched more than 100 products through this.Customised Product Formulations – Veerhealth Care has the capability of manufacturing specialised product formulations customised for the Brands. Due to customisation the products can meet the standard specifications of the Brands.Veerhealth Care has established a new division focused on hospital care, which includes partnering with a leading manufacturer and exporter of medical equipment. This new division will offer a range of equipment, including ventilators, defibrillators, infusion pumps, syringe pumps, and other accessories. Company intends to supply these products to government organizations and hospitals.VeerPlast is a division of Veerhealth Care. It is a plastic moulding company, providing high-quality plastic products to various industries. At VeerPlast, Company takes pride in being a manufacturer of high-quality toothbrushes, dedicated to promoting superior oral hygiene through precision and commitment to excellence.The Company is expecting to get a substantial addition to its revenue in the current financial year. In F.Y. 2025-26, Company is expecting Total Revenues of Rs 305-400 million with PAT of 10 per cent.

Next Story
Infrastructure Urban

BluSmart Faces Insolvency Amid Financial and Governance Troubles

The NCLT appointed NPV Insolvency Professionals as the interim resolution professional (IRP) to take charge of BluSmart’s operations and assets while continuing business as a going concern. The tribunal also ordered full cooperation from the company’s promoters and management until a resolution plan is formulated.Founded by the Jaggi brothers, who also promoted Gensol Engineering, BluSmart’s situation parallels that of Gensol, which the same NCLT bench had admitted into insolvency proceedings earlier in June. Gensol’s fleet of 4,000 vehicles was recently leased across Delhi-NCR and Ben..

Next Story
Infrastructure Transport

DMRC Achieves Tunnel Breakthrough on Golden Line Corridor

Part of the 23.6-km Golden Line, the tunnel breakthrough marks progress on one of the corridor’s 19.3 km of underground sections, which will connect 15 metro stations upon completion.The 91-metre-long TBM completed a 792-metre tunnel stretch designed for up and down train movement. The work is being executed by civil contractor Afcons Infrastructure.Constructed at an average depth of 18 metres, the tunnel features 559 precast concrete rings, each with an internal diameter of 5.8 metres. These segments were manufactured at a mechanised casting yard in Mundka and steam-cured for accelerated st..

Next Story
Infrastructure Transport

MMRDA Deposits Rs 5.60 Bn in Metro Arbitration Case

Following a Supreme Court directive, MMRDA deposited 50 per cent of the Rs 11.69 billion arbitration award in a case related to project cost disputes with MMOPL, which operates Mumbai’s first metro line. The Bombay High Court had earlier asked MMRDA to pay the full award by 15 July 2025.The arbitration award—amounting to Rs 9.92 billion—was granted in August 2023 by a three-member tribunal. MMRDA had contested the order under Section 34 of the Arbitration and Conciliation Act, but the Bombay High Court upheld the award in MMOPL’s favour.The cost of the 12-km Versova–Andheri–Ghatkop..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Talk to us?